MedTrace Logo

A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix

NCT00921635 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2009-06-19

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility, safety and short term effects on health related quality of life, of maintaining hemoglobin from 120 to 130 g/L versus from 100 to 110 g/L, with red cell concentrate (RCC) transfusion, in women having chemo-radiation for cancer of the cervix.

Conditions

Interventions

PROCEDURE

Blood transfusion

Blood transfusion to maintain hemoglobin level above 120 g/L

PROCEDURE

Blood transfusion

Blood transfusion to maintain hemoglobin level above 100 g/L

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER

  • Tri-Service General Hospital

    lead OTHER

Principal Investigators

  • Yee-Min Jen · Randiation Oncology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2011-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921635 on ClinicalTrials.gov